Rafael Holdings, Inc. earnings releases RFL

Annual Quarterly

Rafael Holdings, Inc. last reported quarterly results on Jun 11, 2026, for Q3 FY2026 (the quarter ended Apr 30, 2026): revenue of $179,000 (-50.6% year over year) and diluted EPS of -$0.08. It usually reports 41–44 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 41–44 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Jun 11, 2026 42 days after quarter end	Q3 FY2026 ended Apr 30, 2026	0 -50.6%	-4 +11.6%	-0.08 +57.9%
Mar 16, 2026 44 days after quarter end	Q2 FY2026 ended Jan 31, 2026	0 +174.0%	-6 -38.3%	-0.13 +31.6%
Dec 11, 2025 41 days after quarter end	Q1 FY2026 ended Oct 31, 2025	0 +87.5%	-10 -9.0%	-0.19 +48.6%
Jun 11, 2025 42 days after quarter end	Q3 FY2025 ended Apr 30, 2025	0 +7.7%	-5 +85.2%	-0.19 +86.0%
Mar 14, 2025 42 days after quarter end	Q2 FY2025 ended Jan 31, 2025	0 +13.2%	-5 -176.7%	-0.19 -176.0%
Nov 7, 2024 7 days after quarter end	Q1 FY2025 ended Oct 31, 2024	0 +88.2%	-9 -147.6%	-0.37 -146.7%
Jun 14, 2024 45 days after quarter end	— ended Apr 30, 2024	—	—	—
Mar 14, 2024 43 days after quarter end	— ended Jan 31, 2024	—	—	—

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: RFL (NYSE)
Fiscal year ends: July 31
Incorporated in: DE
Headquarters: Newark, NJ
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1713863

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.